Table 3.

Top 20 vinorelbine-associated AEs in FAERS ranked by frequency of reports.

	Top 20 AEs by frequency of reports	Frequency	ROR (95% Cl)	IC (IC025)
1	Neutropenia	172	12.08 (10.38–14.06)	3.56 (3.25)
2	Fever	127	3.39 (2.84–4.04)	1.74 (1.46)
3	Vomiting	111	2.21 (1.83–2.67)	1.13 (0.84)
4	Dyspnea	110	1.79 (1.48–2.16)	0.83 (0.54)
5	Nausea	109	1.27 (1.05–1.54)	0.34 (0.06)
6	Diarrhea	92	1.34 (1.09–1.65)	0.42 (0.11)
7	Anaemia	78	3.71 (2.97–4.64)	1.88 (1.50)
8	Leukopenia	73	13.59 (10.79–17.12)	3.75 (3.19)
9	Asthenia	72	1.76 (1.39–2.21)	0.80 (0.45)
10	Pneumonia	68	1.84 (1.45–2.34)	0.88 (0.51)
11	Febrile neutropenia	67	9.51 (7.48–12.10)	3.24 (2.71)
12	Interstitial lung disease	61	11.87 (9.23–15.28)	3.56 (2.96)
13	Abdominal pain	58	2.32 (1.79–3.00)	1.20 (0.80)
14	Malignant neoplasm progression	57	5.34 (4.12–6.94)	2.41 (1.92)
15	Acute kidney injury	55	2.55 (1.79–3.33)	1.34 (1.92)
16	Disease progression	54	4.24 (3.24–5.54)	2.07 (1.60)
17	Decreased appetite	54	2.05 (1.57–2.68)	1.03 (0.61)
18	Thrombocytopenia	53	4.40 (3.36–5.76)	2.13 (1.65)
19	Chest pain	50	2.43 (1.84–3.21)	1.27 (0.83)
20	General physical health deterioration	44	3.70 (2.75–4.97)	1.88 (1.36)